Purchase Order 36C26326P0243
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23) awarded Edwards Lifesciences LLC a $34,000 firm fixed-price purchase order for transcatheter aortic valve replacement (TAVR) systems on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract, which carries no set-aside designation, supports the VA's mission to provide specialized cardiac care to veterans in the Minneapolis service area. Edwards Lifesciences LLC, a subsidiary of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on December 5, 2025, with an ultimate completion date of December 8, 2025. This contract, which carries no set-aside designation, is for the procurement of transcatheter aortic valve replacement (TAVR) equipment to support cardiovascular surgical procedures at VA facilities in Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order worth $34,000.00 to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products and services. This order supports the VA's Veteran Integrated Service Network 23 in Minneapolis, Minnesota. Edwards Lifesciences LLC is a global leader in cardiovascular medical devices and has received numerous prime and...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular medical devices. The contract, issued on October 31, 2025, with performance in Minneapolis, Minnesota, represents a non-set-aside procurement of specialized heart valve technology. Edwards Lifesciences LLC, a leading manufacturer of advanced...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on January 12, 2026, for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular devices. The contract, which carries no set-aside designation, is scheduled for completion by January 15, 2026, with performance taking place in Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on November 21, 2025, with an ultimate completion date of November 24, 2025. This contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) medical devices to support veteran healthcare at the Minneapolis, Minnesota facility. Edwards Lifesciences LLC, a subsidiary of Edwards...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on December 19, 2025, with a completion date of December 22, 2025. This contract, classified as TAVR (Transcatheter Aortic Valve Replacement), represents a non-set-aside procurement for specialized cardiovascular medical devices to be delivered to Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis, MN), awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on February 9, 2026, with completion scheduled for February 10, 2026. This contract, issued with no set-aside designation, represents a sole-source procurement reflecting Edwards Lifesciences LLC's exclusive manufacturing capability for these specialized cardiovascular medical devices. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, specializes in the design, manufacture, and distribution of advanced cardiac technologies, including SAPIEN transcatheter heart valves and related surgical implants critical to the VA's cardiac care mission for the veteran population. This purchase order falls within the company's broader portfolio of over 200 federal contract awards received since 2025, predominantly from the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. Edwards Lifesciences LLC maintains two indefinite delivery contracts with the VA totaling $7.45 million—a $6.5 million five-year consignment services agreement with VISN 21 (Palo Alto) and a $950,000 five-year contract with VISN 15—which establish the company as a primary framework supplier of advanced cardiovascular devices to support VA healthcare delivery and veteran surgical outcomes across key service network regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 2/9/26 |